Get notified when MRK files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: MRK Merck & Co., Inc. 8-K

Merck reports Q1 2026 earnings results

Filed April 30, 2026 · Period ending April 30, 2026 · ~1 min read

Key Changes

  • high

    Merck disclosed first quarter 2026 financial results through a press release and supplemental materials. The actual earnings figures, revenue, and performance metrics are contained in the attached exhibits rather than the 8-K body.

  • medium

    Additional supplemental financial information was provided beyond the main earnings release, typically including detailed segment breakdowns, non-GAAP reconciliations, and other metrics not in the press release.

    Exhibit 99.2 verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.

Partner

Trade MRK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · May 17, 2026 · How we verify